Co-dopa CR Tablet 100 mg + 25 mg is a prolonged-release formulation combining Levodopa and Carbidopa, designed for the treatment of Parkinson’s disease and Parkinsonism-related disorders. Parkinson’s disease is a progressive neurological condition characterized by tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability, resulting from a deficiency of dopamine in the brain.

Levodopa, the active component, replenishes dopamine levels, improving motor function and reducing Parkinson’s symptoms. Carbidopa enhances Levodopa’s efficacy by inhibiting its peripheral breakdown, allowing more of the drug to reach the brain while minimizing common side effects like nausea and vomiting. The prolonged-release (CR) formulation ensures a sustained release of medication, providing longer-lasting symptom control and reducing the frequency of dosing.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

How Co-dopa CR Works

Co-dopa CR Tablet works through a dual mechanism:

• Levodopa: Crosses the blood-brain barrier and is converted into dopamine, replenishing the brain’s depleted neurotransmitter levels and improving motor function.

• Carbidopa: Inhibits peripheral decarboxylation of Levodopa, ensuring more Levodopa reaches the brain while reducing gastrointestinal side effects.

• Controlled Release Mechanism: Slowly releases Levodopa over time, providing steadier dopamine levels, reducing “wearing-off” effects, and maintaining more consistent symptom relief throughout the day.

This dual and sustained action helps patients maintain better mobility and overall functional independence.

Indications

Co-dopa CR Tablet 100 mg + 25 mg is indicated for:

• Parkinson’s disease in adults with motor symptoms requiring long-acting medication

• Parkinsonism resulting from idiopathic or neurodegenerative causes

• Management of tremor, rigidity, bradykinesia, and postural instability

• Patients experiencing fluctuations in symptom control with standard immediate-release Levodopa/Carbidopa therapy

It is particularly useful for patients who need extended symptom control to reduce the number of daily doses.

Dosage and Administration

• The dosage is individualized based on the patient’s condition, severity of symptoms, and response to therapy.

• Typically taken 1–2 times daily as directed by a healthcare professional.

• Swallow the tablet whole with water; do not crush, split, or chew, as this will destroy the controlled-release mechanism.

• Can be taken with or without food; taking with food may help reduce nausea.

• Do not stop the medication abruptly to avoid worsening of symptoms or withdrawal effects.

Regular follow-up is essential to optimize dosing and monitor therapeutic response.

Precautions and Warnings

• Use with caution in patients with heart disease, kidney or liver impairment, high blood pressure, or psychiatric conditions.

• Avoid concomitant use with non-selective MAO inhibitors, as this may cause hypertensive crises.

• Monitor for dyskinesias, hallucinations, mood changes, or sudden sleep episodes.

• Pregnant and breastfeeding women should use only under medical supervision.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects include:

• Nausea and vomiting

• Dizziness or lightheadedness

• Low blood pressure (orthostatic hypotension)

• Involuntary movements (dyskinesias)

• Sleep disturbances or vivid dreams

Serious adverse effects are uncommon but require immediate attention if they occur.

Storage Instructions

• Store below 30°C in a dry place

• Keep away from direct sunlight and moisture

• Keep the container tightly closed

• Keep out of reach of children

Co-dopa CR Tablet 100 mg + 25 mg offers prolonged and effective symptom control for Parkinson’s disease, improving motor function, reducing “off” periods, and enhancing overall quality of life for patients.